Nurix Therapeutics, Inc.NRIXNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-305.99%
↓ 13% vs avg
Percentile
P57
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-270.56%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -305.99% | +18.6% |
| 2024 | -375.83% | -94.3% |
| 2023 | -193.45% | +58.4% |
| 2022 | -465.27% | -19.4% |
| 2021 | -389.57% | -10.5% |
| 2020 | -352.43% | -451.5% |
| 2019 | -63.90% | -254.5% |
| 2018 | -18.03% | - |